Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX

Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX

Bibliographic Details
Main Authors:	Alexandre de Nonneville, Roger R. Reddel
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-03-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-021-21794-0

Similar Items

Formal reply to “Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX”
by: Lars Feuerbach
Published: (2021-03-01)

Alternative Lengthening of Telomeres and Loss of ATRX/DAXX Expression in Sarcomas with Clinicopathological Features
by: Jau-Yu Liau, et al.
Published: (2018)

The Role of ATRX in the Alternative Lengthening of Telomeres (ALT) Phenotype
by: João P. Amorim, et al.
Published: (2016-09-01)

Loss of wild-type ATRX expression in somatic cell hybrids segregates with activation of Alternative Lengthening of Telomeres.
by: Kylie Bower, et al.
Published: (2012-01-01)

Impact of DAXX and ATRX expression on telomere length and prognosis of breast cancer patients
by: Marwa T. Hussien, et al.
Published: (2020-08-01)

Alternative lengthening of telomeres: remodeling the telomere architecture
by: Dimitri eConomos, et al.
Published: (2013-02-01)

Structural basis for DAXX interaction with ATRX
by: Xiaoman Wang, et al.
Published: (2017-09-01)

ATRX affects the repair of telomeric DSBs by promoting cohesion and a DAXX-dependent activity.
by: Courtney A Lovejoy, et al.
Published: (2020-01-01)

Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway.
by: Courtney A Lovejoy, et al.
Published: (2012-01-01)

Structural and biochemical characterization of DAXX-ATRX interaction
by: Zhuang Li, et al.
Published: (2017-09-01)

The level of activity of the alternative lengthening of telomeres correlates with patient age in IDH-mutant ATRX-loss-of-expression anaplastic astrocytomas
by: Nathalie Grandin, et al.
Published: (2019-11-01)

Structural and mechanistic insights into ATRX-dependent and -independent functions of the histone chaperone DAXX
by: Dominik Hoelper, et al.
Published: (2017-10-01)

Targeting Telomerase and ATRX/DAXX Inducing Tumor Senescence and Apoptosis in the Malignant Glioma
by: Hueng-Chuen Fan, et al.
Published: (2019-01-01)

The roles of ND10 proteins ATRX and hDaxx in the regulation of herpesvirus infection
by: Lukashchuk, Vera
Published: (2010)

Alternative Lengthening of Telomeres and Chromatin Status
by: Ion Udroiu, et al.
Published: (2019-12-01)

ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner.
by: Jacqueline A Brosnan-Cashman, et al.
Published: (2018-01-01)

Prognostic Significance of Altered ATRX/DAXX Gene in Pancreatic Neuroendocrine Tumors: A Meta-Analysis
by: Fei Wang, et al.
Published: (2021-06-01)

Defining mechanisms that regulate the alternative lengthening of telomeres
by: Mason-Osann, Emily
Published: (2020)

Replication stress and the alternative lengthening of telomeres pathway
by: Cox, Kelli
Published: (2016)

EBV tegument protein BNRF1 disrupts DAXX-ATRX to activate viral early gene transcription.
by: Kevin Tsai, et al.
Published: (2011-11-01)

HP1-mediated formation of alternative lengthening of telomeres-associated PML bodies requires HIRA but not ASF1a.
by: Wei-Qin Jiang, et al.
Published: (2011-01-01)

ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
by: Chang S. Chan, et al.
Published: (2018-10-01)

Alternative Lengthening of Telomeres in the Budding Yeast Naumovozyma castellii
by: Marita Cohn, et al.
Published: (2019-10-01)

Pan-Cancer Analysis of Alternative Lengthening of Telomere Activity
by: Ji-Yong Sung, et al.
Published: (2020-08-01)

Alternative Lengthening of Telomeres in Pediatric Cancer: Mechanisms to Therapies
by: Thomas Kent, et al.
Published: (2020-01-01)

Single-molecule analysis of subtelomeres and telomeres in Alternative Lengthening of Telomeres (ALT) cells
by: Heba Z. Abid, et al.
Published: (2020-07-01)

The FANCM-BLM-TOP3A-RMI complex suppresses alternative lengthening of telomeres (ALT)
by: Robert Lu, et al.
Published: (2019-05-01)

Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT)
by: Marco De Vitis, et al.
Published: (2018-02-01)

Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres
by: Timothy P. Lippert, et al.
Published: (2021-01-01)

Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome
by: Sabine A. Hartlieb, et al.
Published: (2021-02-01)

Alternative lengthening of telomeres: from molecular mechanisms to therapeutic outlooks
by: Jia-Min Zhang, et al.
Published: (2020-03-01)

Role of FANCM in Alternative Lengthening of Telomeres (ALT) Human Cells
by: Al Murshedi, Fathiya
Published: (2010)

Role of FANCM in Alternative Lengthening of Telomeres (ALT) Human Cells
by: Al Murshedi, Fathiya
Published: (2010)

Defining RAD54 function in the alternative lengthening of telomeres pathway
by: Terranova, Katherine
Published: (2020)

Author Correction: The FANCM-BLM-TOP3A-RMI complex suppresses alternative lengthening of telomeres (ALT)
by: Robert Lu, et al.
Published: (2019-11-01)

Alternative Lengthening of Telomeres: Recurrent Cytogenetic Aberrations and Chromosome Stability under Extreme Telomere Dysfunction
by: Despoina Sakellariou, et al.
Published: (2013-11-01)

A Role for Human DNA Polymerase λ in Alternative Lengthening of Telomeres
by: Elisa Mentegari, et al.
Published: (2021-02-01)

The Role of Alternative Lengthening of Telomeres Mechanism in Cancer: Translational and Therapeutic Implications
by: Marta Recagni, et al.
Published: (2020-04-01)

The effect of Telomere Lengthening on Genetic Diseases
by: Marko Bojkovic, et al.
Published: (2021-03-01)

ALT control, delete: FANCM as an anti-cancer target in Alternative Lengthening of Telomeres
by: Julienne J O’Rourke, et al.
Published: (2019-01-01)